Text: H.R.1121 — 116th Congress (2019-2020)All Information (Except Text)

There is one version of the bill.

Text available as:

Shown Here:
Introduced in House (02/08/2019)


116th CONGRESS
1st Session
H. R. 1121


To amend title III of the Social Security Act to permit States to conduct substance abuse risk assessments and targeted drug testing as a condition for the receipt of unemployment benefits, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

February 8, 2019

Mr. Carter of Georgia (for himself, Mr. Chabot, Mr. Allen, Mr. Cole, Mr. Loudermilk, Mr. Westerman, Mr. Duncan, Mr. Rouzer, Mr. Mitchell, Mr. Wright, Mr. DesJarlais, and Mr. Weber of Texas) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned


A BILL

To amend title III of the Social Security Act to permit States to conduct substance abuse risk assessments and targeted drug testing as a condition for the receipt of unemployment benefits, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Ensuring Quality in the Unemployment Insurance Program (EQUIP) Act”.

SEC. 2. Drug screening made a condition of benefit receipt.

(a) In general.—Section 303(l) of the Social Security Act (42 U.S.C. 503(l)) is amended to read as follows:

“(l) (1) Nothing in this Act or any other provision of Federal law shall be considered to prevent a State from enacting legislation to provide for testing an applicant for unemployment compensation for the unlawful use of controlled substances as a condition for receiving such compensation, including legislation that provides for the following procedures:

“(A) No regular compensation may be paid to an applicant for such compensation with respect to a benefit year unless, before the receipt of any such compensation—

“(i) the applicant has completed a substance abuse risk assessment for such benefit year; and

“(ii) subject to subparagraph (B), if the State determines based on the results of such assessment that the applicant is a high-risk applicant, not later than 1 week after the results of the assessment are determined, the applicant tests negative for controlled substances.

“(B) If a high-risk applicant tests positive for any controlled substance—

“(i) if such test result is the first positive test result for such applicant in the benefit year—

“(I) no regular compensation may be paid to such applicant for a period of 30 days beginning on the date that such test result is determined; and

“(II) no regular compensation may be paid to such applicant during the remainder of such benefit year unless the applicant tests negative for controlled substances at the end of such period;

“(ii) if such test result is not the first positive test result for such applicant in the benefit year, no regular compensation may be paid to such applicant during the remainder of such benefit year.

“(C) A high-risk applicant receiving benefits with respect to a benefit year shall be subject to testing for controlled substances by the State at any time during the benefit year, with limited notice provided to the applicant of such testing.

“(D) A high-risk applicant who is tested for controlled substances under—

“(i) subparagraph (A) or (C) shall be responsible for the cost of such test if the individual tests positive for any such substance; and

“(ii) subparagraph (B)(i)(II) shall be responsible for the cost of such test.

“(2) For purposes of this subsection—

“(A) the term ‘benefit year’ means the benefit year as defined in the applicable State law;

“(B) the term ‘controlled substance’—

“(i) means a drug or other substance selected by the State to be included in drug testing under this subsection; and

“(ii) does not include any drug or other substance used by the applicant pursuant to a valid prescription or as otherwise authorized by law;

“(C) the term ‘high-risk applicant’, with respect to a benefit year, means an individual who is determined by the State to have a high risk of substance abuse based on the results of a substance abuse risk assessment administered under paragraph (1)(A)(i); and

“(D) the term ‘substance abuse risk assessment’ means a screening instrument, approved by the Director of the National Institutes of Health, designed to determine whether an individual has a high risk of substance abuse.”.

(b) No merit staffing requirements.—Section 303(a)(1) of the Social Security Act (42 U.S.C. 503(a)(1)) shall not be construed in such a manner as to apply the merit staffing requirements in section 900.603 of title 5, Code of Federal Regulations, as in effect on October 1, 2011, to the implementation of section 303(l) of such Act (as amended by subsection (a)).

(c) Funding for substance abuse testing.—

(1) FUNDING FROM IPAB.—Section 1899A(m) of the Social Security Act (42 U.S.C. 1395kkk(m)) is amended—

(A) in paragraph (1), in the matter preceding subparagraph (A), by striking “to the Board to carry” and inserting “for the purposes of carrying out section 303(l), and, if any funds remain in the fiscal year involved, for the Board for the purpose of carrying”; and

(B) by striking paragraph (2).

(2) FUNDING FROM THE CO-OP PROGRAM.—Section 1322(g) of the Patient Protection and Affordable Care Act (42 U.S.C. 18042(g)) is amended by striking “to carry out this section” and inserting “to carry out section 303(l) of the Social Security Act, to the extent funds are necessary to carry out such section after the application of section 1899A(m)(1) of such Act”.